MorphoSys to buy Constellation Pharma for $1.7 billion; Constellation's stock soars 61%
Shares of MorphoSys AG ADR MOR, -12.90% were down 8.9% in premarket trading on Wednesday after the company announced a $1.7 billion...
MorphoSys to buy Constellation Pharma for $1.7 billion; Constellation's stock soars 61%
eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement
Sana Biotechnology Presents Preclinical Data at AACR Meeting 2021
Nuvation Bio Granted Orphan Drug Designation for NUV-422 for Patients with Malignant Gliomas
Vir Biotechnology and GSK Announce VIR-7831 Reduces Hospitalization and Risk of Death in Early Treat
GlaxoSmithKline doubles down on Vir pact, throwing in $345M upfront to go beyond COVID-19
Nuvation Bio Closes Transaction with Panacea, Debuts as Publicly Traded Oncology Company
Sana snags $587.5M IPO to catapult cell therapies into the clinic
Gilead Sciences and Gritstone Announce Collaboration For HIV Cure